Every one of those 1 sits in a single category, disruptions. Of the tracked stories, 1 of 1 also mention Adani Total Gas, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 3.2 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Polymedicure
Every one of those 1 sits in a single category, disruptions. Of the tracked stories, 1 of 1 also mention Adani Total Gas, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 3.2 for the same window. The 7 average consequence score is below the beat benchmark of 7.4 in the same window. We currently track 1 Supply Chain story that mention Polymedicure, all published on March 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 46 Supply Chain stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Polymedicure. Shared-story counts are live from our verified record — not editorial picks.
A critical shortage of polypropylene and domestic gas rationing is threatening India's medical device manufacturing sector, specifically for syringes and IV bags. Driven by the Iran war and logistical bottlenecks, raw material costs have surged up to 35% in less than two weeks, placing 90% of the industry's SMEs at risk.